Status:
COMPLETED
Digital Health Interventions for Obsessive Compulsive Disorder (OCD)
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
Koa Health B.V.
Conditions:
Obsessive-Compulsive Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The investigators are testing two digital health interventions for obsessive compulsive disorder (OCD). The investigators hope that these digital health programs will increase access to treatment for ...
Detailed Description
The primary aims of this study are to test the feasibility, acceptability, and efficacy of two digital health interventions for adults with OCD recruited nationally. Eligible subjects (N=120) will be ...
Eligibility Criteria
Inclusion
- At least 18 years of age
- Current diagnosis of primary obsessive compulsive disorder (OCD), based on the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), Mini International Neuropsychiatric Interview (MINI)
- Currently living in the United States
Exclusion
- Psychotropic medication changes within 2 months prior to enrollment (Participants taking psychotropic medication must have been on a stable dose for at least 2 months prior to enrollment and not change medication during study period)
- Past participation in ≥4 sessions of cognitive behavioral therapy (CBT) for OCD
- Past use of a CBT for OCD app
- Current severe substance use disorder
- Lifetime bipolar disorder or psychosis
- Acute, active suicidal ideation as indicated by clinical judgment and/or a score ≥2 on the suicidal ideation subscale of the Columbia Suicide Severity Rating Scale (C-SSRS).
- Current severe comorbid major depression, as indicated by clinical judgment and/or a Quick Inventory of Depressive Symptomatology, self-report version (QIDS-SR), total score ≥ 21
- Current post-traumatic stress disorder (PTSD)
- Concurrent psychological treatment
- Does not own a supported mobile smartphone with a data plan
- Lack of technology literacy that would interfere with ability to engage with smartphone treatment
Key Trial Info
Start Date :
July 26 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 25 2024
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04136626
Start Date
July 26 2021
End Date
October 25 2024
Last Update
November 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114